,
Bawa, Kritleen K.
Krance, Saffire H.
Herrmann, Nathan
Cogo-Moreira, Hugo
Ouk, Michael
Yu, Di
Wu, Che-Yuan
Black, Sandra E.
Lanctôt, Krista L.
Swardfager, Walter https://orcid.org/0000-0002-0030-8908
Funding for this research was provided by:
Alzheimer's Association (AARG501466)
Brain Canada (AARG501466)
Michael J. Fox Foundation (N/A)
Weston Brain Institute (N/A)
Alzheimer’s Research UK (N/A)
Sunnybrook Research Institute (N/A)
Alzheimer's Association (N/A)
Article History
Received: 16 December 2019
Accepted: 17 February 2020
First Online: 14 March 2020
Ethics approval and consent to participate
: ADNI was conducted according to Good Clinical Practice guidelines, US 21CFR Part 50–Protection of Human Subjects, and Part 56–Institutional Review Boards, and pursuant to state and federal regulations. HIPAA authorizations and written informed consent were obtained from all study participants and/or authorized representatives, and study partners.
: Not applicable.
: The authors declare that they have no competing interests.